Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Expert Highlights Progress With Molecular Biomarkers in GI Cancers

March 1st 2018

Michael J. Pishvaian, MD, discusses expanded testing for biomarkers, using liquid biopsies to predict response to treatment, and the importance of identifying increasingly specific subsets of GI cancers to make treatment decisions.

Potentially Transformative Treatments Emerge in Pancreatic Cancer

March 1st 2018

Allyson Ocean, MD, discusses the development of novel therapeutic regimens in pancreatic cancer.

First Liver Transplant Surgery Performed in Patient With CRC Metastases

February 28th 2018

Although the standard-of-care treatment for patients with liver metastases developing from colorectal cancer is liver resection, only one-third of these patients are candidates for surgery.

Dr. He on the Future of Precision Medicine in GI Malignancies

February 27th 2018

Aiwu Ruth He, MD, PhD, associate professor of medicine, Georgetown-Lombardi Comprehensive Cancer Center, discusses the future of precision medicine in gastrointestinal malignancies.

Dr. Morse Reflects on Recent Data in Advanced CRC

February 27th 2018

Michael A. Morse, MD, professor, Medicine, Department of Surgery, Duke University School of Medicine, Duke Cancer Institute, reflects on recent data in advanced colorectal cancer.

Future Outlook in Pancreatic Cancer

February 27th 2018

Promising New Therapies in Pancreatic Cancer

February 27th 2018

Pancreatic Cancer: Looking Beyond Second-Line Therapy

February 27th 2018

Immunotherapy in MSI-High Pancreatic Tumors

February 27th 2018

Second-Line Decision-Making in Pancreatic Cancer

February 27th 2018

Impact of Second-Line Approval of Liposomal Irinotecan

February 27th 2018

Pancreatic Cancer: Data With Liposomal Irinotecan/5-FU

February 27th 2018

Dosing Options With Nab-Paclitaxel/Gemcitabine

February 27th 2018

Sequencing Strategies in Pancreatic Cancer

February 27th 2018

Choosing Frontline Therapy in Metastatic Disease

February 27th 2018

Recent Advances in Pancreatic Cancer Research

February 27th 2018

Hepatocellular Carcinoma: Future Role of Immunotherapy

February 27th 2018

Optimizing Checkpoint Inhibitor Combinations in HCC

February 27th 2018

KEYNOTE-224: Improving HCC Outcomes With Pembrolizumab

February 27th 2018

Hepatocellular Carcinoma: Recent Approval of Nivolumab

February 27th 2018